STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZBH
  4. [Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity

Zimmer Biomet (NYSE: ZBH) director receives new phantom stock unit grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zimmer Biomet Holdings, Inc. director Maria Teresa Hilado received a grant of phantom stock units as part of her non-employee director compensation. She acquired 378.873 phantom stock units tied on a 1-for-1 basis to common stock value, bringing her total phantom stock units to 11,684.719.

These units were accrued under the company’s Deferred Compensation Plan for Non-Employee Directors and will be settled in cash through ten annual installments starting within sixty days after the calendar year in which her board service ends. The total includes 30.381 units added earlier through the plan’s dividend reinvestment provision.

Positive

  • None.

Negative

  • None.
Insider Hilado Maria Teresa
Role Director
Type Security Shares Price Value
Grant/Award Phantom Stock Units 378.873 $0.00 --
Holdings After Transaction: Phantom Stock Units — 11,684.719 shares (Direct)
Footnotes (1)
  1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. The Conversion or Exercise Price of Derivative Security is 1-for-1. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Phantom stock units granted 378.873 units Grant to director on 2026-03-31
Total phantom units after grant 11,684.719 units Holdings following reported transaction
Dividend reinvestment units 30.381 units Accrued on January 30, 2026 via dividend reinvestment
Installment count 10 annual installments Cash settlement schedule after director service ends
Payout start window Within 60 days After end of calendar year of service cessation
Conversion ratio 1-for-1 Phantom stock units to Zimmer Biomet common stock value
Phantom Stock Units financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Deferred Compensation Plan for Non-Employee Directors financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
dividend reinvestment provision financial
"Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hilado Maria Teresa
(Last)(First)(Middle)
345 E. MAIN STREET
(Street)
WARSAW INDIANA 46580
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Units(1)$89.08(2)03/31/2026A378.873 (3) (3)Common Stock378.873$011,684.719(4)D
Explanation of Responses:
1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
4. Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Theresa Maria Hilado (power of attorney previously filed)04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did ZIMMER BIOMET (ZBH) director Maria Teresa Hilado report in this Form 4?

Maria Teresa Hilado reported receiving 378.873 phantom stock units as a compensation-related grant. These units track Zimmer Biomet common stock value and increased her total phantom stock holdings to 11,684.719 units under the company’s Deferred Compensation Plan for Non-Employee Directors.

What are phantom stock units in the context of ZIMMER BIOMET (ZBH)?

Phantom stock units are cash-settled awards whose value mirrors Zimmer Biomet common stock on a 1-for-1 basis. They are bookkeeping entries under the Deferred Compensation Plan for Non-Employee Directors, giving economic exposure to the stock without issuing actual shares.

How and when will Maria Teresa Hilado’s ZBH phantom stock units be paid out?

Her phantom stock units will be settled in cash over ten annual installments. Payments begin within sixty days after the end of the calendar year in which her service as a Zimmer Biomet director ceases, spreading the compensation over a multi-year period.

How many phantom stock units does Maria Teresa Hilado hold after this ZBH grant?

After the reported grant, she holds a total of 11,684.719 phantom stock units. This total includes the newly awarded 378.873 units and previously accrued amounts, such as 30.381 units added earlier through the plan’s dividend reinvestment provision.

What is the role of dividend reinvestment in ZBH’s phantom stock unit plan?

Under the dividend reinvestment provision, cash-equivalent dividends are credited as additional phantom stock units. For Hilado, this added 30.381 units on January 30, 2026, increasing her deferred compensation balance in line with dividends on Zimmer Biomet common shares.